Immune response may be harnessed to control HIV, primary trial results suggest

by

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies.

Leave A Comment

Your email address will not be published. Required fields are marked *